The Canadian Network for Statistical Training in Trials (CANSTAT) is a multi-institutional national program hosted at McMaster that trains junior statisticians in clinical trials and addresses the critical shortage of biostatisticians in Canada.
The startup is working on a first-in-class precision medicine that will prevent secondary metastatic brain cancer. It's an innovation that could revolutionize the future of cancer care.
Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is caused by a single antibody – overturning decades of medical misunderstanding.
McMaster logo
McMaster logo
